A bill to amend the Federal Food, Drug and Cosmetic Act to allow increased inspection of records.

Summary

Amends the Federal Food, Drug, and Cosmetic Act to extend the inspection authority of the Food and Drug Administration (FDA) over records ( currently limited to manufacturers and distributors of prescription drugs) to manufacturers and distributors of drugs containing caffeine and ephedrine. Permits the Secretary of Health and Human Services to add additional substances to this list, through notice and comment rulemaking, if they become substances of abuse. Prohibits the manufacture and distribution of drugs which a reasonable person would believe to be a controlled substance. Repeals the prohibition on obtaining injunctions against the manufacturers and distributors of counterfeit drugs and the making, selling or concealing of the equipment used to make counterfeit drugs. Extends the FDA's seizure authority to prohibited look-alike drugs.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Introduced in Senate

  summary · EN · 14 November 1983

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.